Pricing Log in Create free account

Bluejay Diagnostics, Inc. (BJDX) vs GlucoTrack, Inc. (GCTK)

Bluejay Diagnostics, Inc. and GlucoTrack, Inc. are both Medical Devices companies. Bluejay Diagnostics, Inc. is the larger, with a market value of $2.5M against $1.7M — 1.5× the size. Across the 8 metrics below, Bluejay Diagnostics, Inc. leads on 5 and GlucoTrack, Inc. on 3.

Valuation

Metric BJDX GCTK Medical Devices median
P/E n/m n/m 24.94
P/S n/m 0.24 2.66
P/B 0.52 n/m 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m n/m 11.42
EV/Sales n/m 4.16 2.76
Earnings yield (368.94%) (100,122.63%) (12.66%)
Free cash flow yield (127.64%) (32,549.37%) (7.18%)

Profitability

Metric BJDX GCTK Medical Devices median
Gross margin 0.00% 0.00% 57.76%
Operating margin 0.00% 0.00% (14.84%)
Net margin 0.00% 0.00% (14.45%)
Free cash flow margin 0.00% 0.00% (5.70%)
Return on equity (98.89%) (620.63%) (10.56%)
Return on assets (81.07%) (272.48%) (17.26%)
Return on invested capital 0.00% 0.00% (5.22%)

Growth

Metric BJDX GCTK Medical Devices median
Revenue growth (TTM) — (60.61%) 10.41%
EPS growth (last fiscal year) 96.66% 99.17% 28.17%
Revenue growth, 5-year CAGR — 28.31% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BJDX GCTK Medical Devices median
Debt to equity 0.00 (1.11) 0.04
Current ratio 4.64 0.46 2.67
Net debt to EBITDA 0.76 0.25 0.54

Dividend

Metric BJDX GCTK Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric BJDX GCTK Medical Devices median
Market cap 2.45m 1.65m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack